Express News | Milestone Scientific Shares Are Trading Higher After the Company Announced Medicare Pricing for Its CompuFlo Epidural System Within the First JMAC Region Covering Covering Florida
Express News | Milestone Scientific Announces Favorable Medicare Pricing for Its Compuflo® Epidural System Within First Jmac Region Covering Florida
Express News | EXCLUSIVE: Milestone Scientific Tells Benzinga 'Additionally, the Company Reports That It Is Making Progress on Its Reimbursement Strategy in Additional JMAC Regions'
Express News | EXCLUSIVE: Milestone Scientific Tells Benzinga Co. Announces Favorable Medicare Pricing For Its CompuFlo Epidural System Within First JMAC Region Covering Florida
Express News | Milestone Scientific Receives Regulatory Approval to Market Compuflo® Epidural System in Brazil
Express News | Milestone Scientific Receives ANVISA Approval To Market CompuFlo Epidural System In Brazil; Aims To Expand Addressable Market With Technological Advantages; Brazil Conducts 4-5M Epidural Procedures Annually
Milestone Scientific Receives Regulatory Approval to Market CompuFlo Epidural System in Brazil
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to
Milestone Scientific: A Buy Rating on Strong Financials and Market Expansion Potential
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2024 Earnings Conference
The following is a summary of the Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript:Financial Performance:Milestone Scientific recorded Q1 2024 revenue of $2.2 million, seeing a slight
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript
Express News | Milestone Scientific Q1 2024 GAAP EPS $(0.02), Inline, Sales $2.249M Miss $2.416M Estimate
Express News | Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Express News | Milestone Scientific Q1 Revenue USD 2.2 Million
Express News | Milestone Scientific Q1 Gross Profit USD 1.7 Million
Press Release: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024 Sales through new online portal increase 31% over the same period last year Gross marg
Milestone Scientific | 10-Q: Quarterly report
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that
Milestone Scientific Commences Sales of CompuFlo Epidural Disposables Within PRC Alliance Pain Relief Center in Ormond Beach, Florida
PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND, N.J., April 03,
Milestone Scientific: A Strong Buy on Robust Financials and Market Expansion Potential
Milestone Scientific Inc. (AMEX:MLSS) Q4 2023 Earnings Call Transcript
No Data